Target Healthcare REIT (THRL) Share Price, News & Analysis

Company Overview

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Key Stats

• Today's Range: 84 to 86
• 50-Day Range: 79.70 to 88.80
• 52-Week Range: 75 to 93.10
• Volume: 605,844 shs
• Average Volume: 976,545 shs
• Market Capitalization: £520.29 million
• P/E Ratio: 7.12
• Dividend Yield: 7.06%
• Price Target: N/A
• Consensus Rating: N/A

THRL Stock Analysis - Frequently Asked Questions

How have THRL shares performed this year?

Target Healthcare REIT's stock was trading at GBX 83.99 at the beginning of the year. Since then, THRL shares have increased by 1.2% and is now trading at GBX 85.
View the best growth stocks for 2025 here.

How do I buy shares of Target Healthcare REIT?

Shares of THRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Target Healthcare REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Target Healthcare REIT investors own include Realty Income (O), AT&T (T), Cambian Group (CMBN), Meta Platforms (META), Pfizer (PFE), Primary Health Properties (PHP) and Aviva (AV).

Company Calendar

• Ex-Dividend for 11/29 Dividend: 11/14/2024
• Dividend Payable: 11/29/2024
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: LON:THRL
• CUSIP: N/A
• CIK: N/A
• Web: www.targethealthcarereit.co.uk
• Phone: +44-131-6252951
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 11.93
• Trailing P/E Ratio: 7.12
• Forward P/E Ratio: 13.66
• P/E Growth: 1.48
• Net Income: £72.07 million
• Net Margins: 104.99%
• Pretax Margin: N/A
• Return on Equity: 10.78%
• Return on Assets: 3.86%

Debt

• Debt-to-Equity Ratio: 34.92
• Current Ratio: 7.20
• Quick Ratio: 1.52

Sales & Book Value

• Annual Sales: £68.64 million
• Price / Sales: 7.58
• Cash Flow: GBX 5.92 per share
• Price / Cash Flow: 14.37
• Book Value: GBX 111.13 per share
• Price / Book: 0.76

Miscellaneous

• Outstanding Shares: 612,105,168
• Free Float: N/A
• Market Cap: £520.29 million
• Optionable: Not Optionable
• Beta: 0.44